Terms: = Breast cancer AND NCOR1, hCIT529I10, 9611, ENSG00000141027, N-CoR, MGC104216, TRAC1, O75376, hN-CoR, KIAA1047 AND Prognosis
8 results:
1. Identifying Genomic Alterations in Patients With Stage IV breast cancer Using MammaSeq: An International Collaborative Study.
Shah OS; Soran A; Sahin M; Knapick BA; Ugras S; Celik E; Lucas PC; Lee AV
Clin Breast Cancer; 2021 Jun; 21(3):210-217. PubMed ID: 33191115
[TBL] [Abstract] [Full Text] [Related]
2. ER-Negative breast cancer Is Highly Responsive to Cholesterol Metabolite Signalling.
Hutchinson SA; Lianto P; Roberg-Larsen H; Battaglia S; Hughes TA; Thorne JL
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31683867
[TBL] [Abstract] [Full Text] [Related]
3. SNP mutation-related genes in breast cancer for monitoring and prognosis of patients: A study based on the TCGA database.
Gao C; Zhuang J; Zhou C; Li H; Liu C; Liu L; Feng F; Liu R; Sun C
Cancer Med; 2019 May; 8(5):2303-2312. PubMed ID: 30883028
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of transcriptionally regulated genes identifies ncor1 in hormone receptor negative breast tumors and lung adenocarcinomas as a potential tumor suppressor gene.
Noblejas-López MDM; Morcillo-García S; Nieto-Jiménez C; Nuncia-Cantarero M; Győrffy B; Galan-Moya EM; Pandiella A; Ocaña A
PLoS One; 2018; 13(11):e0207776. PubMed ID: 30485330
[TBL] [Abstract] [Full Text] [Related]
5. Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609).
Liang X; Briaux A; Becette V; Benoist C; Boulai A; Chemlali W; Schnitzler A; Baulande S; Rivera S; Mouret-Reynier MA; Bouvet LV; De La Motte Rouge T; Lemonnier J; Lerebours F; Callens C
J Hematol Oncol; 2018 Oct; 11(1):124. PubMed ID: 30305115
[TBL] [Abstract] [Full Text] [Related]
6. KLF17 attenuates estrogen receptor α-mediated signaling by impeding ERα function on chromatin and determines response to endocrine therapy.
Ali A; Ielciu I; Alkreathy HM; Khan AA
Biochim Biophys Acta; 2016 Jul; 1859(7):883-95. PubMed ID: 27107895
[TBL] [Abstract] [Full Text] [Related]
7. The molecular diversity of Luminal A breast tumors.
Ciriello G; Sinha R; Hoadley KA; Jacobsen AS; Reva B; Perou CM; Sander C; Schultz N
Breast Cancer Res Treat; 2013 Oct; 141(3):409-20. PubMed ID: 24096568
[TBL] [Abstract] [Full Text] [Related]
8. ncor1 mRNA is an independent prognostic factor for breast cancer.
Zhang Z; Yamashita H; Toyama T; Sugiura H; Ando Y; Mita K; Hamaguchi M; Hara Y; Kobayashi S; Iwase H
Cancer Lett; 2006 Jun; 237(1):123-9. PubMed ID: 16019133
[TBL] [Abstract] [Full Text] [Related]